JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ENDV - Endonovo Therapeutics, Inc.
USD | OTC Markets | Healthcare
Summary
Summary ENDV Stock
Financials
Financials ENDV Stock
Loading...
Loading...
Income Statement
Income Statement ENDV Stock
Balance Sheet
Balance Sheet ENDV Stock
Cash Flow Statement
Cash Flow Statement ENDV Stock
Loading...
Loading...
ENDV Financials - Endonovo Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Endonovo Therapeutics, Inc. (ENDV)
Financials
Financials of ENDV
Loading...
Loading...
Loading...
Loading...
Revenue
$135.355K
Operating Income
$-3.26434M
Net Income
$-18.474835M
Share Count (Basic)
139.206511M
Operating Cash Flow
$-678.838K
Free Cash Flow
N/A
Cash And Short-Term Equivalents
N/A
Total Debt
$7.153245M
Annual
Quarterly
Revenue $USD
0
100K
200K
300K
FY2018
FY2019
FY2020
FY2021
FY2022
Revenue $USD
0
50K
100K
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23
Annual
Quarterly
Net Income $USD
-20M
-15M
-10M
-5M
0
Annual
Quarterly
Margins
Gross
Operating
Net
-10000%
-5000%
0%
FY2018
FY2019
FY2020
FY2021
FY2022
Net Income $USD
-10M
-5M
0
5M
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23
FY2018
FY2019
FY2020
FY2021
FY2022
Margins
Gross
Operating
Net
-40000%
-20000%
0%
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23